162 related articles for article (PubMed ID: 16331610)
21. Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients.
Challouf S; Ziadi S; Zaghdoudi R; Ksiaa F; Ben Gacem R; Trimeche M
Clin Chim Acta; 2012 Apr; 413(7-8):795-802. PubMed ID: 22296674
[TBL] [Abstract][Full Text] [Related]
22. RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma.
Kang S; Lee JM; Jeon ES; Lee S; Kim H; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
Int J Cancer; 2006 Sep; 119(6):1316-21. PubMed ID: 16619251
[TBL] [Abstract][Full Text] [Related]
23. [Methylation and aberrant expression of the p16 gene in cervical carcinoma].
Yuan JR; Li Y; Hu SJ; Li P
Yi Chuan; 2005 Jan; 27(1):39-43. PubMed ID: 15730957
[TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung.
Licchesi JD; Westra WH; Hooker CM; Herman JG
Clin Cancer Res; 2008 May; 14(9):2570-8. PubMed ID: 18451218
[TBL] [Abstract][Full Text] [Related]
25. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
[TBL] [Abstract][Full Text] [Related]
26. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
Velasco A; Pallares J; Santacana M; Gatius S; Fernandez M; Domingo M; Valls J; Yeramian A; Encinas M; Dolcet X; Matias-Guiu X
Hum Pathol; 2011 Feb; 42(2):185-93. PubMed ID: 21111454
[TBL] [Abstract][Full Text] [Related]
27. Association between RASSF1A Promoter Hypermethylation and Oncogenic HPV Infection Status in Invasive Cervical Cancer: a Meta-analysis.
Li JY; Huang T; Zhang C; Jiang DJ; Hong QX; Ji HH; Ye M; Duan SW
Asian Pac J Cancer Prev; 2015; 16(14):5749-54. PubMed ID: 26320446
[TBL] [Abstract][Full Text] [Related]
28. Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data.
Yang HJ; Liu VW; Wang Y; Tsang PC; Ngan HY
BMC Cancer; 2006 Aug; 6():212. PubMed ID: 16928264
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
[TBL] [Abstract][Full Text] [Related]
30. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
31. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
32. Methylation of the RASSF1A gene promoter in Uigur women with cervical squamous cell carcinoma.
Pan Z; Li J; Pan X; Chen S; Wang Z; Li F; Qu S; Shao R
Tumori; 2009; 95(1):76-80. PubMed ID: 19366060
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.
Liau JY; Liao SL; Hsiao CH; Lin MC; Chang HC; Kuo KT
Hum Pathol; 2014 Mar; 45(3):533-9. PubMed ID: 24440092
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
Clin Cancer Res; 2003 Apr; 9(4):1441-5. PubMed ID: 12684417
[TBL] [Abstract][Full Text] [Related]
35. [Promoter methylation of DAPK gene in cervical carcinoma].
Zhao XL; Meng ZY; Qiao YH; Zhang HL
Ai Zheng; 2008 Sep; 27(9):919-23. PubMed ID: 18799028
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
Murao K; Kubo Y; Ohtani N; Hara E; Arase S
Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
[TBL] [Abstract][Full Text] [Related]
37. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
38. Aberrant DNA methylation of apoptotic signaling genes in patients responsive and nonresponsive to therapy for cervical carcinoma.
Chaopatchayakul P; Jearanaikoon P; Yuenyao P; Limpaiboon T
Am J Obstet Gynecol; 2010 Mar; 202(3):281.e1-9. PubMed ID: 20117760
[TBL] [Abstract][Full Text] [Related]
39. [Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof].
Cong DG; Wang SF
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2932-4. PubMed ID: 18261310
[TBL] [Abstract][Full Text] [Related]
40. Selective expression of HERG and Kv2 channels influences proliferation of uterine cancer cells.
Suzuki T; Takimoto K
Int J Oncol; 2004 Jul; 25(1):153-9. PubMed ID: 15202000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
